Popular Representations of Race: The News Coverage of BiDil

See generally, Bates B. R. , “Public Culture and Public Understanding of Genetics: A Focus Group Study,” Public Understanding of Science 14, no. 1 (2005): 47–65; Ten Eyck T. A. , “The Media and Public Opinion on Genetics and Biotechnology: Mirrors, Windows, or Walls?” Public Understanding of Science 14, no. 3 (2005): 305–316.

See Holtzman N. A. , “The Quality of Media Reports on Discoveries Related to Human Genetic Diseases,” Community Genetics 8, no. 3 (2005): 133–144; Marks L. , “Mass Media Framing of Biotechnology News,” Public Understanding of Science 16, no. 2 (2007): 183–203.

See generally, Ten Eyck T. Williment M. , “The National Media and Things Genetic: Coverage in the New York Times (1971–2001) and the Washington Post (1977–2001),” Science Communication 25, no. 2 (2003): 129–152; Petersen A. , “Biofantasies: Genetics and Medicine in the Print News Media,” Social Science and Medicine 52, no. 8 (2001): 1255–1268; Hornig Priest S. , “Public Discource and Scientific Controvery: A Spiral-of-Silence Analysis of Biotechnology Opinion in the United States,” Science Communcication 28, no. 2 (2006): 195–215; and Kitzinger J. Williams C. , “Forecasting Science Futures: Legitimizing Hope and Calming Fears in the Embryo Stem Cell Debate,” Social Science and Medicine 61, no. 3 (2005): 731–740.

Nelkin D. , “Molecular Metaphors: The Gene in Popular Discourse,” Nature Review Genetics 2 (2001): 555–559.

News , “‘Black’ Pill: A Good Case of Racial Profiling,” Minneapolis Star Tribune, November 12, 2004, at A18.

Nelkin D. Lindee S. , The DNA Mystique: The Gene as Cultural Icon (New York: W. H. Freeman, 1995).

Wade N. , “Race-Based Medicine Continued…,” New York Times, November 14, 2004, at 12.

Caulfield T. Bubela T. Murdoch C. J. , “Myriad and the Mass Media: The Covering of a Gene Patent Controversy,” Genetics in Medicine 9, no. 12 (2007): 850–855; Bubela T. Caulfield T. , “Do the Print Media ‘Hype’ Genetic Research?: A Comparison of Newspaper Stories and Peer-Reviewed Research Papers,” Canadian Medical Association Journal 170, no. 9 (2004): 1399–1407.

Stein R. , “FDA Approves Controversial Heart Medication for Blacks,” Washington Post, June 24, 2005, at A15.

Bailey R. , “When Medicine that Discriminates Is Good: Using Race and Ethnicity to Improve Health Care Is Anything but Racist,” Chicago Sun-Times, December 18, 2006, at B2.

Roylance F. D. , “A Sort of Scientific Malpractice: Genetics: Scientists Are Cautioning Doctors against the Use of Race as a Guide in Diagnosis, Treatment, and Research,” Baltimore Sun, October 11, 2004, at 1A.

Eunjung Cha A. , “Race Plays Role in New Drug Trials,” Washington Post, July 28, 2003, at A01.

Auge K. , “Race Research Moves Cautiously,” The Denver Post, April 19, 2005, at B1.

See, for example, Marantz Henig R. , “The Genome in Black and White (and Gray),” New York Times, October 10, 2004, at 47.

Rowland C. , “Panel Backs Drug for Blacks,” Boston Globe, June 17, 2005, at E1.

Editorial, “The First Race-Based Medicine,” New York Times, June 19, 2005, at 11.

Caulfield T. , “Nutrigenomics, Popular Representations and the Reification of ‘Race,’” Health Law Review 16, no. 3 (2008): 50–57.

Highfield R. , “Selling Science to the Public,” Science 289, no. 5476 (2000): 59.

Kahn J. , “Raceing Patents/Patenting Race: An Emerging Political Geography of Intellectual Property in Biotechnology,” Iowa Law Review 92, no. 2 (2007): 353–416.

Cho M. , “Racial and Ethnic Categories in Biomedical Research: There Is No Baby in the Bathwater,” Journal of Law, Medicine & Ethics 34, no. 3 (2006): 497–499; Ellison G. Smart A. Tutton R. Outram S. Ashcroft R. , “Racial Categories in Medicine: A Failure of Evidence-Based Practice?” PLoS Medicine 4, no. 9 (2007): 1434–1436.

Editorial, “Improve Access to Heart Drug,” Grand Rapid Press, December 11, 2006, at A6.

Syre S. , “Potential vs. Reality,” Boston Globe, June 1, 2005, at D1.

Nisbet M. Mooney C. , “Framing Science,” Science 316 (2007): 56.

Condit C. M. Parrott R. Bates B. R. Bevan J. Achter P. J. , “Exploration of the Impact of Messages about Genes and Race on Lay Attitudes,” Clinical Genetics 66, no. 5 (2004): 402–408, 406; see also Singer E. Antonucci T. C. Burmeister M. Couper M. P. Raghunathan T. E. Van Hoewyk J. , “Beliefs about Genes and Environment as Determinants of Behavioral Characteristics,” International Journal of Public Opinion 19, no. 3 (2007): 331–353.

Bates B. R. , “Evaluating Direct-to-Consumer Marketing of Race-Based Pharmacogenomics: A Focus Group Study of Public Understandings of Applied Genomic Medication,” Journal of Health Communication 9, no. 6 (2004): 541–559.

For example, see Kolata G. , “Genes Explain Race Disparity in Response to a Heart Drug,” New York Times, April 29, 2008; BBC News, “Race Differences in Immune Genes,” BBC News, February 29, 2008, available at <http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/7270562.stm> (last visited June 3, 2008); and Talaga T. , “Race Affects Asthma Tests, Study Finds,” Toronto Star, January 8, 2008, available at <http://www.thestar.com/living/Health/article/292031> (last visited June 3, 2008).

See, for example, Bubela T. Caulfield T. , “Do the Print Media ‘Hype’ Genetic Research?: A Comparison of Newspaper Stories and Peer-Reviewed Research Papers,” Canadian Medical Association Journal 170, no. 9 (2004): 1399–1407; and Gething L. , “‘Them and Us’: Scientists and the Media — Attitudes and Experiences,” South Africa Medical Journal 93, no. 3 (2003): 197–201.